Cargando…
The epidemiology of aggressive pituitary tumors (and its challenges)
Pituitary tumors are not rare if prevalence rates from autopsy or radiological series are considered; approximately 0.5% of all pituitary adenomas will come to medical attention. Less than 0.1% of these pituitary adenomas will become malignant, and probably around 0.5% of all detected adenomas will...
Autores principales: | Dekkers, Olaf M., Karavitaki, Niki, Pereira, Alberto M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303064/ https://www.ncbi.nlm.nih.gov/pubmed/32361816 http://dx.doi.org/10.1007/s11154-020-09556-7 |
Ejemplares similares
-
Endocrinology in the time of COVID-19: Management of pituitary tumours
por: Fleseriu, Maria, et al.
Publicado: (2020) -
Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to
Treatment
por: Burman, Pia, et al.
Publicado: (2023) -
Mortality in patients with non-functioning pituitary adenoma
por: Tampourlou, Metaxia, et al.
Publicado: (2018) -
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients
por: Burman, Pia, et al.
Publicado: (2022) -
Future treatment strategies of aggressive pituitary tumors
por: Lamberts, Steven W. J., et al.
Publicado: (2008)